share print

Transparency

 
DISCLOSURE OF TRANSFERS OF VALUES TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS

We believe that collaboration with medical community is the key to identifying patients’ needs, developing innovative medicines and enhancing the quality of health education.

To foster a better understanding of how these collaborations work, we have committed to disclose the payments made to healthcare professionals (HCP) and healthcare organisations (HCO) under the EFPIA Disclosure Code.
More information about the EFPIA Disclosure code is
available on the EFPIA Website.

Below are links to the reports for the countries where HRA Pharma has transfers of values to disclose. Please refer to the Global Methodological Note that describes our disclosure methods used to prepare this annual disclosure report.

In some countries disclosure reports are published on central platforms. In these cases, you will be directed to a third party website.

Global Methodological Note

Belgium – Disclosure Report 2015
Finland
Disclosure Report 2015
Disclosure Report 2016 (English version)
Germany – Disclosure Report 2015
Hungary – Disclosure Report 2015
Italy – Disclosure Report 2015
Poland – Disclosure Report 2015
Spain – Disclosure Report 2015
Sweden
- Disclosure Report 2015
Disclosure Report 2016 (English Version)
Switzerland – Disclosure Report 2015
UK – Disclosure Report 2015


 
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?